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 O BJECTIVES :  To investigate the prevalence of leishmaniasis in dogs in the  UK and to describe clinical 
presentation, clinicopathological abnormalities, therapeutic protocols and outcome in this non-endemic 
country. 
 M ATERIALS AND M ETHODS :  Medical records of dogs diagnosed with leishmaniasis at seven referral centres in 
the  UK were retrospectively reviewed. 
 R ESULTS :  The prevalence was between 0·007 and 0·04% with a higher number of cases in southern 
England. All dogs had a history of travel to or from an endemic country. Lethargy, dermatological disease, 
decreased appetite and lameness were the most common reasons for presentation. Allopurinol was 
used alone for treatment in the majority of cases. 
 C LINICAL S IGNIFICANCE :  Although rare, leishmaniasis should be considered in dogs in the  UK if they have 
compatible clinical signs and history of travel to or from endemic areas. 
 INTRODUCTION 
 Canine leishmaniasis (CanL) is a systemic zoonotic disease 
caused by the protozoan  Leishmania infantum . Infected dogs are 
the main reservoir of the parasite (Baneth  et al.  2008 ) and play an 
important role in the epidemiology of human visceral (HVL) and 
cutaneous (HCL) leishmaniasis. Approximately 0·2 to 0·4 and 
0.7 to 1.2 million HVL and HCL cases, respectively, occur each 
year. More than 90% of global HVL cases occur in six countries: 
India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. 
HCL is more widely distributed with about one-third of cases 
occurring in each of three epidemiological regions, the Americas, 
the Mediterranean Basin, and western Asia from the Middle East 
to Central Asia (Alvar  et al.  2012 ). CanL is endemic in more 
than 70 countries worldwide (Solano-Gallego  et al.  2011 ) and 
especially in the Mediterranean areas of Europe (Cyprus, Greece, 
Albania, Croatia, Italy, Malta, France, Spain and Portugal) (Maia 
& Cardoso  2015 ), the Middle East and many tropical and sub-
tropical areas of the world. However, the infection is spreading to 
non-endemic areas with an increasing number of cases reported 
in dogs living in North America (Gaskin  et al.  2002 , Duprey  et al. 
 2006 ) and northern Europe (Shaw  et al.  2009 , Maia & Cardoso 
 2015 ). Recent studies have documented the disease in Germany 
(Geisweid  et al.  2012 ), UK (Shaw  et al.  2009 ) and Netherlands 
(Teske  et al.  2002 ). This is probably due to a wider spread of the 
vector and, especially, to a larger numbers of dogs being imported 
from, or having visited, endemic countries. Since the introduc-
tion of the UK Pet Travel Scheme (PETS) in 2000, the number 
of dogs travelling into the UK has increased year after year with a 
total of 411,582 dogs recorded between 2000 and January 2008 
(Mencke  2011 ). As a result, the disease has gained importance 
JSAP_12503.indd   1 27/05/16   7:28 PM
P. Silvestrini et al.
 
2 Journal of Small Animal Practice  •  © 2016 British Small Animal Veterinary Association
in the UK, albeit largely limited to the dogs that travel. It is 
likely that only very little natural transmission occurs in the UK 
because environmental conditions prevent the viability of the 
vector (Shaw  et al.  2009 ). However, other mechanisms of trans-
mission are possible, including blood transfusion (de Freitas  et al. 
 2006 ), vertical (Rosypal & Lindsay  2005 , Pangrazio  et al.  2009 , 
Boggiatto  et al.  2011 , Naucke & Lorentz  2012 , Turchetti  et al. 
 2014 ) and venereal transmission (Diniz  et al.  2006 ). Despite 
the increase in awareness, the prevalence of infected dogs enter-
ing the UK is unknown, because no pre-or post-travel testing 
is required. Furthermore, clinically apparent cases represent the 
minority of infected dogs in endemic areas (Solano-Gallego  et al. 
 2009 , Schallig  et al.  2013 ), so dogs with subclinical infection that 
appear healthy may unknowingly be imported. 
 Only one study (Shaw  et al.  2009 ) has previously investigated 
dogs with positive diagnostic tests for CanL in the UK. The 
objectives of this study were, firstly, to investigate the prevalence 
of leishmaniasis in a canine population attending referral centres 
in the UK and, secondly, to describe clinical presentation, most 
frequent clinicopathological abnormalities, diagnostic investiga-
tions, different therapeutic protocols used and outcome of dogs 
diagnosed with CanL in this non-endemic country. 
 MATERIALS AND METHODS 
 Patients and eligibility 
 Medical records of dogs diagnosed of clinical leishmaniasis in 
seven different referral centres in the UK (University of Liver-
pool, University of Bristol, University of Edinburgh, Uni-
versity of Cambridge, Royal Veterinary College of London, 
Anderson Moores Veterinary Specialists, Animal Health Trust), 
between January 2005 and January 2014, were retrospectively 
reviewed. The database of each institution was searched by use 
of the  following terms: leishmaniasis, leishmaniosis, allopurinol, 
N-methylglucamine antimoniate and miltefosine. Dogs on ther-
apy with allopurinol for diseases other than CanL were excluded. 
In this way only patients with a final diagnosis of clinical leish-
maniasis were selected and then included. The prevalence of the 
disease was calculated as the ratio between the number of cases 
diagnosed of CanL in the study period at each referral centre and 
the total canine population that attended the respective centre in 
the same time period. The study was approved by the Veterinary 
Research Ethics Committee of the University of Liverpool. 
 Data collection 
 The diagnosis of CanL was made when there were compat-
ible clinical signs and/or laboratory abnormalities together 
with detection of the parasites by polymerase chain reaction 
(PCR) or cytology (from lymph node, bone marrow, spleen or 
skin), and/or detection of antibodies using an immunofluores-
cence assay (IFAT) or an enzyme-linked immunosorbent assay 
(ELISA). Where available, information was reviewed regarding 
travel history (i.e. country to which the dog had travelled or from 
where it had been imported), reasons for presentation, physical 
 examination findings, results of diagnostic investigations (e.g. 
haematology, biochemistry, urinalysis, cytology, serology, and 
PCR), therapeutic protocol used, and outcome. Dogs were tested 
for other vector-borne diseases ( Ehrlichia canis, Babesia canis ) if a 
co-infection was suspected. Survival time was defined as time (in 
days) from first presentation to last re-check or to time of death. 
 Diagnostic investigations 
 All routine clinicopathological analyses, serology, and real-time 
quantitative PCR (qPCR) assays were conducted at the respective 
university or by commercial laboratories. Clinicopathological 
abnormalities such as anaemia, azotaemia and hypoalbuminae-
mia were defined when results were outside the reference inter-
vals established by each corresponding laboratory. Proteinuria 
was diagnosed by an elevated urine protein-to-creatinine ratio 
(UPCR>0·5) with inactive urinary sediment. Renal azotaemia 
was defined as increased creatinine with concurrent isosthenuria 
(1·008 to 1·012). 
 For serological investigations, the upper reference interval for 
IFAT was either 1:80 or 1:128, depending on the laboratory, 
whilst the positive threshold value for ELISA used by all labora-
tories was 35 ELISA Units (EU). Serological results were classi-
fied as low, medium or high positive if IFAT titres were less than 
twofold, two to fourfold, or greater than fourfold greater than 
the threshold positive value indicated by the reference laboratory. 
ELISA results were classified as mild when less than 80 EU, mod-
erate when between 80 and 150 EU, and high when greater than 
150 EU. Detection and quantification of  Leishmania kinetoplas-
tic DNA was performed on blood, bone marrow, and/or skin 
samples by qPCR as previously described (Caldin  et al.  2004 , 
Solano-Gallego  et al.  2007 , Maia & Campino  2008 ). 
 Classification of cases 
 Dogs were classified at the time of diagnosis into different clini-
cal stages according to the Canine Leishmaniasis Working Group 
(CLWG) guidelines (Paltrinieri  et al.  2010 ). Dogs were also clas-
sified according to the International Renal Interest Society (IRIS) 
guidelines, based on measurement of serum creatinine concen-
tration at the first two appointments. 
 Statistical analysis 
 Data are reported as median or mean and range (minimum and 
maximum). 
 RESULTS 
 Patient population 
 Thirty-eight dogs were included in the study: 14 were diagnosed 
at the Royal Veterinary College, 7 at the University of Liverpool, 
7 at the University of Edinburgh, 3 at the University of Bristol, 
3 at the University of Cambridge, 3 at the Animal Health Trust 
and 1 at Anderson Moores Veterinary Specialists. Median age was 
4·8 years (range 1·11 to 12·2 years) and median body weight was 
26·3 kg (range 5·9 to 49 kg). The prevalence of the disease was 
0·007 to 0·04%; the higher values (0·04% at the Royal  Veterinary 
College of London, 0·03% at the University of Bristol and 
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0·02 % at the Animal Health Trust) were found in southern 
 England. 
 All dogs had a history of having travelled to, or been imported 
from, an endemic area for  Leishmania infantum . No clini-
cal or clinicopathological differences were noted between dogs 
imported from and dogs that have travelled to an endemic area. 
No autochthonous cases were found in this population. Details 
of patient and travel history are presented in Table  1 . 
 Detection of  Leishmania infantum and concurrent 
vector-borne diseases 
 Leishmania infantum infection was demonstrated by serology 
and/or PCR and/or cytology. Details of the diagnostic tests are 
shown in Table  2 . Only three dogs were tested for other vec-
tor-borne diseases, including two dogs tested by serology for 
 Ehrlichia canis and one for  Babesia canis; all tests were negative. 
 Clinical signs 
 All dogs had at least one clinical sign compatible with leishmani-
asis. The most frequent reasons for presentation were lethargy 
(20/38, 53%), dermatological lesions (17/38, 45%), decreased 
appetite and lameness (8/38, 21%). On physical examination the 
most common signs observed were dermatological signs (24/38, 
63%, including localised or multifocal alopecia [10], and crust-
 Table 1 .  Patient population and travel history 
Number of dogs (%) 
Mixed breed 12 (31%) 
Labrador retriever 4 (10%) 
Lurcher 3 (8%) 
Cocker spaniel 2 (5%) 
Golden retriever 2 (5%) 
Staff bull terrier 2 (5%) 
Basset hound 1 (3%) 
Border collie 1 (3%) 
Boxer 1 (3%) 
English pointer 1 (3%) 
English setter 1 (3%) 
Greek hare hound 1 (3%) 
Greyhound 1 (3%) 
Siberian husky 1 (3%) 
Labradoodle 1 (3%) 
Miniature poodle 1 (3%) 
Miniature schnauzer 1 (3%) 
Rottweiler 1 (3%) 
Spanish galgo 1 (3%) 
Neutered males 18 (47%) 
Neutered females 15 (40%) 
Entire males 3 (8%) 
Entire female 2 (5%) 
 Imported from 32 (84%) 
Spain 16 (42%) 
Greece 7 (18%) 
Cyprus 3 (8%) 
Italy 2 (5%) 
Portugal 2 (5%) 
Hungary 1 (3%) 
Brazil 1 (3%) 
 Travelled to 6 (16%) 
Spain 3 (8%) 
France 2 (5%) 
Germany 1 (3%)
 Table 2 .  Diagnostic tests used to indentify  Leishmania 
infantum infection 
Number of dogs (%) 
Serology + PCR 10 (26%) 
Serology + PCR + cytology 8 (21%) 
Serology 7 (18%) 
PCR 7 (18%) 
Serology + cytology 3 (8%) 
PCR + cytology 2 (5%) 
Cytology 1 (2%) 
 Serology 28 (74%) 
ELISA 19 (68%) 
IFAT 9 (32%) 
 Mild  7 (25%) 
 Moderate  11 (39%) 
 High  10 (36%) 
 PCR 27 (71%) 
Blood 12 (44%) 
Spleen 4 (15%) 
Lymph node 3 (11%) 
Bone marrow 2 (7%) 
Blood + bone marrow 2 (7%) 
Blood + spleen 1 (4%) 
Spleen + lymph node 1 (4%) 
Blood + conjunctiva + skin 1 (4%) 
Blood + bone marrow + joint fluid 1 (4%) 
 Cytology 14 (37%) 
Lymph node 8 (57%) 
Spleen 3 (22%) 
Bone marrow 2 (14%) 
Lymph node + spleen 1 (7%)
 Table 3 .  Main clinico-pathological findings 
Number of dogs (%) 
Anaemia 19/32 (60%) 
Thrombocytopenia 8/23 (35%) 
Leukopenia 7/22 (32%) 
Pancytopenia 2/22 (9%) 
Azotaemia ( increased urea and/or creatinine ) 17/30 (57%) 
Renal azotaemia ( increased creatinine and 
isosthenuria )
6/25 (24%) 
Hyperproteinaemia 20/30 (67%) 
Hypoalbuminaemia 28/30 (93%) 
Hyperglobulinaemia 28/30 (93%) 
Decreased A/G ratio 28/30 (93%) 
Hyperphosphataemia 10/23 (43%) 
Hyperkalaemia 4/23 (17%) 
Isosthenuria (1.008 to 1.012) 16/26 (61%) 
Proteinuria (UPC>0.5) 19/28 (68%)
 USG Urine specific gravity, UPC urine protein/urine creatinine ratio 
ing dermatitis [8]) and systemic lymphadenopathy (22/38, 
58%). Twenty-four percent (9/38) of dogs were diagnosed with 
polyarthritis. 
 Clinicopathological investigations 
 Table  3 shows the main clinicopathological findings. All dogs 
had at least one laboratory abnormality compatible with leish-
maniasis. In total, 19/32 dogs (60%) were anaemic, with the 
anaemia being classified as mild (haematocrit [HCT] 30 to 36%) 
and moderate (HCT 18 to 29%) in 11 (58%) and 8 dogs (42%), 
respectively, and non-regenerative (reticulocytes<60×10 9 /L) in 
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four of the six cases for which a reticulocyte count was avail-
able. Eight dogs (8/23, 35%) had thrombocytopoenia (median: 
94×10 9 /L, range: 30 to 150; laboratory reference interval: 155 to 
400) and 2 (2/22, 9%) were pancytopoenic. Renal azotaemia was 
detected in six dogs (6/25, 24%), and 20 dogs (20/30, 67%) were 
classified in IRIS stage 1 CKD (creatinine<125 µmol/L), 4 (4/30, 
13%) in IRIS stage 2 (creatinine between 125 to 180 µmol/L) 
and 6 (6/30, 20%) in IRIS stage 3 (creatinine between 181 to 
440 µmol/L). None of the dogs were classified in IRIS stage 4 
CKD (creatinine>440 µmol/L). Nineteen (19/28, 78%) of dogs 
were proteinuric based on increased urine protein-to-creatinine 
ratio (median: 5·6, range: 0·7 to 18·8; normal  values<0.5). 
Finally, 28 dogs (28/30, 93%) were hypoalbuminaemic 
(median: 16 g/L, range: 11 to 20, laboratory reference interval: 
23 to 31),  hyperglobulinaemic (median: 58 g/L, range: 52·1 to 
70;  laboratory reference interval: 25 to 45) and had a low (<0·6) 
albumin/globulin ratio. Serum protein electrophoresis was rarely 
used in the diagnostic work-up and/or in the follow-up rechecks. 
 Treatment 
 Of the 38 cases, 35 (92%) were given a specific treatment for 
CanL. In 17 of the 35 cases (48%) allopurinol was used alone, 
allopurinol and miltefosine were used in 15 (43%) and allopu-
rinol and N-methylglucamine antimoniate used in 3 (9%) dogs. 
A variety of other drugs were used in addition to the anti- Leish-
mania therapy, depending upon the specific case and attending 
clinician ’ s judgement, including ace-inhibitors (benazepril, enal-
april), anti-hypertensive drugs (amlodipine), anti-thrombotics 
(clopidogrel, aspirin) analgesics and anti-inflammatory drugs 
(tramadol, meloxicam), gastro-protectants (sucralfate, famoti-
dine), anti-emetics (maropitant, ondansetron, metoclopramide), 
immune-suppressive drugs (prednisolone, azathioprine), diuret-
ics (spironolactone) and antibiotics (doxycycline, amoxicillin-
clavulanate, enrofloxacin and marbofloxacin). 
 Staging and survival 
 Based on CLWG clinical staging, 32/38 dogs (84%) were classi-
fied as stage C (sick dogs with clinically evident leishmaniasis), 
and 6 (16%) as stage D (severely sick dogs often unresponsive to 
repeated courses of anti- Leishmania drugs). Twenty-eight (74%) 
dogs were alive at the end of the study period and 10 (26%) 
had died or had been euthanased. Six of the 10 non-surviving 
dogs (60%) were classified in stage D and four (40%) in stage C. 
Median survival time was 400 days (range 2 to 2160 days). Rea-
sons for death and/or euthanasia included worsening of kidney 
disease (3/10), lack of response to therapy (3/10), acute thrombo-
embolism (1/10), neurological signs due to myelomalacia likely 
secondary to severe systemic vasculitis (1/10) and development 
of lymphoma (1/10) and osteosarcoma (1/10). 
 DISCUSSION 
 This is the first time that clinical CanL has been described in all 
its aspects in a UK dog population. The prevalence of the  disease 
was low, although the real prevalence of the disease is likely 
higher because no cases from primary practices were included. 
Furthermore, only dogs with clinical leishmaniasis were consid-
ered, with either exposed or infected animals (those having posi-
tive results to the diagnostic tests but not showing any clinical 
and clinicopathological abnormalities of the disease) excluded. It 
is unpredictable whether those dogs will develop clinical signs in 
the future. Moreover, due to the low familiarity of the veterinary 
surgeons in the UK with this disease, it is possible that some cases 
could have been missed because CanL was not considered among 
the possible differentials or clients could have declined serology 
testing. 
 Unfortunately, the time between the travel from/to endemic 
areas and the development of clinical signs was not available for 
many cases. On the other hand, it is well known that the time 
between infection and development of clinical signs (incubation 
period) can be very variable and mainly dependent on the host 
immunologic response (Fisa  et al.  1999 , Cardoso  et al.  2007 ). 
 Similar to previous reports (Shaw  et al.  2009 ), most cases were 
found in southern England, although this was not a systematic 
nationwide study and not all geographical regions across the UK 
were included. If cases from the south are genuinely overrepre-
sented, it might be because of the easier connections to Europe 
and warmer weather. The climate has recently changed enough 
to support the transmission and diffusion of other vector-borne 
diseases in the southern part of the UK (Medlock  et al.  2007 , 
Wilson  et al.  2013 ). However, to date a vector of  Leishmania 
infantum has not been found in the UK and sand flies that are 
introduced into the country by car or plane likely die soon after 
arrival because of the weather. The sand fly ’ s range of activity is 
between 15 and 28°C in association with high relative humidity 
and absence of strong rain and winds (Killick-Kendrick  1999 , 
Bogdan  et al.  2001 , Maroli  et al.  2013 ). To date, there is little 
published information regarding the distribution of the compe-
tent sand fly in northern Europe and in the UK and how, or if, it 
is changing. Furthermore, other modes of transmission including 
blood transfusion (de Freitas  et al.  2006 ), vertical transmission 
from bitches to puppies (Rosypal & Lindsay  2005 , Pangrazio 
 et al.  2009 , Boggiatto  et al.  2011 , Naucke & Lorentz  2012 , Tur-
chetti  et al.  2014 ) and venereal transmission (Diniz  et al.  2006 ) 
are known. Dog-to-dog mechanisms have also been suggested to 
explain leishmaniasis outbreaks among foxhounds in the USA 
and Canada (Duprey  et al.  2006 ). 
 All dogs included in this study had a history of having trav-
elled to, or been imported from, a region endemic for  Leishma-
nia infantum . Thirty-two of the 38 dogs were imported and the 
remaining six had travelled to an endemic country, suggesting a 
higher risk in adopting a dog from an endemic area compared 
to travelling to those countries. Travelling dogs usually stay for 
only a short period time and the overall risk they get infected 
with  Leishmania infantum is likely low (Hamel  et al.  2011 ). Nev-
ertheless, veterinarians in non-endemic regions should be aware 
of CanL, including its non-vectorial transmission modes, and 
advise dog owners on preventive measures (Shaw  et al.  2009 , 
Menn  et al.  2010 ). The majority of dogs had been in Spain, 
which has a high prevalence of leishmaniasis (Mattin  et al.  2014 ) 
and is a popular holiday destination. Imported shelter and stray 
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dogs have higher risk to be infected because they undergo fewer 
preventive measures and have greater exposure to sand flies dur-
ing the period of peak of activity (evening) (Manzillo  et al.  2006 ). 
No autochthonous cases were recognised in this study, which 
contrasts the findings of Shaw  et al. ( 2009 ) who identified three 
positive dogs obtained from UK re-homing centres with no his-
tory of travel abroad. It remains questionable if transmission was 
due to vectors, transplacental or even by direct contact. 
 The spectrum of clinical signs and laboratory abnormalities in 
the study group of dogs was similar to that reported in endemic 
areas (Ciaramella  et al.  1997 , Koutinas  et al.  1999 , Paltrinieri 
 et al.  2010 , Solano-Gallego  et al.  2011 ). Dermatological signs 
and lymphadenopathy were the most frequent clinical findings. 
Polyarthritis was diagnosed in nine dogs (24%), similar to previ-
ous UK reports (17%, Shaw  et al.  2009 ), and should be consid-
ered a possible indication of leishmaniasis. The most frequent 
clinico-pathological abnormalities found in the study group 
included mild-to-moderate anaemia, renal azotaemia, hyperglob-
ulinaemia, hypoalbuminaemia, decreased albumin/globulin ratio 
and proteinuria, which are also hallmarks of CanL in endemic 
areas (Ciaramella  et al.  1997 , Koutinas  et al.  1999 , Paltrinieri 
 et al.  2010 , Solano-Gallego  et al.  2011 ). 
 Given the non-pathognomonic clinical signs and laboratory 
abnormalities and relative unfamiliarity with the disease in the 
UK, more than one test was used to confirm the final diagno-
sis in most cases. PCR on peripheral blood lacks sensitivity and 
lymph nodes, spleen and bone marrow harbour a higher number 
of  Leishmania amastigotes (Caldin  et al.  2004 ). Although serum 
protein electrophoresis was included in the initial diagnostic 
investigation only a very low number of cases were re-checked 
using this modality. This test can provide important informa-
tion, especially during reassessment, because improvement or 
normalisation of the protein electrophoresis trace generally hap-
pens before a negative serology titre occurs ( Torres  et al. 2011). 
At time of diagnosis, we recommend haematology, biochem-
istry profile, urinalysis including urine protein-to-creatinine 
ratio, serology titre and serum protein electrophoresis. In case 
of peripheral lymphadenopathy and/or skin lesions, fine-needle 
aspiration for cytology and/or PCR can be also useful. After the 
first month of therapy, previous abnormal parameters can be re-
checked together with serum protein electrophoresis which will 
be the first to show an improvement of previous hypoalbumi-
naemia and hyperglobulinaemia (usually polyclonal gammopa-
thy). At this stage, a significant reduction of the serology titre is 
unlikely. The latter is generally re-evaluated at 3 and 6 months 
from diagnosis together with quantitative PCR on lymph nodes, 
spleen and/or bone marrow that can demonstrate a progressive 
reduction of the number of amastigotes. 
 The majority of dogs were treated with allopurinol alone, 
most likely because N-methylglucamine antimoniate is not avail-
able in the UK and must be imported and miltefosine requires 
a special treatment certificate. Where additional anti- Leishmania 
drugs were used, miltefosine was more frequently used than 
N- methylglucamine antimoniate, probably because it is an 
oral solution and easier to administer. In contrast, N-methyl-
glucamine antimoniate must be injected subcutaneously, and 
can often be associated with localised pain and inflammation. 
Both drugs have been shown to be similarly effective (Miró  et al. 
 2009 ). Currently, N-methylglucamine antimoniate or miltefos-
ine in association with allopurinol are recommended as standard 
therapy for CanL (Oliva  et al.  2010 , Solano-Gallego  et al.  2011 , 
Roura  et al.  2013 , Noli & Saridomichelakis  2014 ). 
 Some dogs also received other drugs according to the attend-
ing clinician ’ s decision. The influence of these drugs on the anti-
 Leishmania therapy and outcome is unknown. 
 Considering that most dogs were treated only with allopuri-
nol, it is noteworthy that the overall outcome was good, espe-
cially since only dogs with moderate-to-severe disease (stages C 
and D) were included and that these animals generally have a 
guarded-to-poor prognosis in endemic areas (Solano-Gallego 
 et al.  2011 , Roura  et al.  2013 ). This finding can, perhaps, be 
explained by the minimal chance of re-infection given the geo-
graphical location, and low risk of having another vector-borne 
disease (Shaw  et al.  2009 ), although this cannot be completely 
ruled out in this study population because only three dogs were 
tested for these. Response to CanL is known to be influenced by 
both concurrent disease and immunological stimulation or sup-
pression by shifting the balance from a protective Th1 response 
to a Th2 immune response that favours the development of a 
non-protective and possibly detrimental humoral reaction (Kou-
tinas & Koutinas  2014 ). 
 Most non-surviving dogs showed progressive kidney disease 
and advanced renal failure is generally the major cause of death 
in CanL (Plannelas  et al.  2009 ). Further studies evaluating IRIS 
staging in a larger population, and also in patients already on 
therapy, could provide more useful information regarding its pos-
sible prognostic value. Finally, all dogs in clinical stage D died or 
were euthanased. Currently, clinical staging at time of diagnosis 
and periodic re-classification in line with disease progression and 
regression is considered a useful way to predict outcome (Solano-
Gallego  et al.  2009 , Oliva  et al.  2010 , Paltrinieri  et al.  2010 ). 
 In conclusion, although it is a rare disease, veterinary surgeons 
in the UK should consider the possibility of leishmaniasis in dogs 
in which there are compatible clinical signs and clinicopathologi-
cal abnormalities and which have a history of travel to or from 
endemic areas. Early diagnosis and appropriate therapy can be 
associated with a relatively good control of the disease (Roura 
 et al.  2013 ; Torres  et al. 2011). Because  Leishmania infection has 
a long incubation period practitioners should instruct owners of 
imported dogs to retest them for  Leishmania for at least 2 years 
after importation or should clinical suspicion increase (Paltrinieri 
 et al.  2010 ). Moreover, veterinarians should be aware of non-vec-
torial transmission and advise clients on preventative measures 
before travelling to endemic countries. 
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